Back to PathoKing

TB module

Tuberculosis

Follow inhaled Mycobacterium tuberculosis through macrophage survival, granuloma formation, latency, reactivation, cavitation, transmission, and multidrug treatment.

intermediate34 min

Clinically reviewed by Mark · NMC-registered nurse

Aetiology

What starts Tuberculosis?

Different triggers converge on the condition's central pathological process.

Recent airborne exposure

Typical setting: An infectious pulmonary or laryngeal case generates respirable droplet nuclei.

Duration, proximity, ventilation, and source bacillary burden determine inoculum.

Impaired cellular immunity

Typical setting: HIV, anti-TNF therapy, transplantation, steroids, or haematological malignancy weakens T-cell macrophage activation.

Granulomas fail to contain latent bacilli or new infection.

Social and environmental risk

Typical setting: Crowding, homelessness, imprisonment, migration from high-incidence settings, and barriers to care increase exposure and delayed diagnosis.

Repeated contact and prolonged infectious periods sustain transmission.

Metabolic vulnerability

Typical setting: Malnutrition, diabetes, smoking, alcohol dependence, and chronic kidney disease impair host defence.

Reduced immune effectiveness increases progression and poor outcomes.

Young or advanced age

Typical setting: Immature or waning cellular immunity reduces containment.

Disseminated and meningeal disease are particular concerns in young children.

Mechanism chain

Cause and effect

Follow each link and use it to predict the next clinical consequence.

1

Droplet nuclei reach alveoli

Bacilli avoid proximal clearance and are engulfed by macrophages.

2

Intracellular bacilli persist

Early innate killing is incomplete and organisms multiply locally.

Checking account access...